Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,738
datasets available to search
ShareScore release 0.9.0
Dataset results
2,738 results for “Multiple sclerosis”
French Registry for Monitoring Pregnancies for Multiple Sclerosis
ClinicalTrials.gov study NCT03900221. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
ClinicalTrials.gov study NCT05447143. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effect of Emotional Freedom Technique on Depression, Anxiety and Distress of Individuals With Multiple Sclerosis
ClinicalTrials.gov study NCT04969562. IPD Sharing: NO. Countries: 1. Publications: 0.
A Cross-sectional Study to Assess the Effectiveness and Safety of Ofatumumab (Kesimpta®) in Patients With Relapsing Multiple Sclerosis in the Spanish Clinical Practice
ClinicalTrials.gov study NCT06251986. IPD Sharing: NO. Countries: 1. Publications: 0.
Ocrelizumab Effects on Physiological and Cognitive Changes in Multiple Sclerosis
ClinicalTrials.gov study NCT03025269. IPD Sharing: NO. Countries: 1. Publications: 0.
Linking Cognitive Functioning to Multimodal Imaging in Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT03723356. IPD Sharing: YES. Countries: 1. Publications: 0.
Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment
ClinicalTrials.gov study NCT02471222. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Methylphenidate as Treatment Option of Fatigue in Multiple Sclerosis
ClinicalTrials.gov study NCT01879202. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Does Long-Term Natalizumab (NTZ) Therapy Normalize Brain Atrophy Rates and Quality of Life (QOL) in Relapsing Remitting Multiple Sclerosis (RRMS)?
ClinicalTrials.gov study NCT02588053. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical and Urodynamic Assessment of Bladder Sensation in Multiple Sclerosis
ClinicalTrials.gov study NCT05772637. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Effects of Motor Imagery and Action Observation in People With Multiple Sclerosis
ClinicalTrials.gov study NCT05377476. IPD Sharing: NO. Countries: 1. Publications: 0.
Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a?
ClinicalTrials.gov study NCT00534261. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis
ClinicalTrials.gov study NCT06220669. IPD Sharing: YES. Countries: 10. Publications: 0.
Artificial Intelligence-Assisted Magnetic Resonance Imaging for Quality, Efficiency and Equity in the National Health Service (NHS) Care of Multiple Sclerosis
ClinicalTrials.gov study NCT07111637. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Reeducation Program to Effort to Improve the Walking of Multiple Sclerosis Patients
ClinicalTrials.gov study NCT02874677. IPD Sharing: NO. Countries: 1. Publications: 0.
Teriflunomide Concentration in Serum and Cerebrospinal Fluid From Patients With Multiple Sclerosis
ClinicalTrials.gov study NCT04129736. IPD Sharing: NO. Countries: 1. Publications: 0.
Video Game-based Therapy for Arm Weakness In Progressive Multiple Sclerosis
ClinicalTrials.gov study NCT03094364. IPD Sharing: YES. Countries: 1. Publications: 0.
Levetiracetam in Central Pain in Multiple Sclerosis(MS)
ClinicalTrials.gov study NCT00423527. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis
ClinicalTrials.gov study NCT01848327. IPD Sharing: YES. Countries: 1. Publications: 0.
Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy
ClinicalTrials.gov study NCT00493077. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.